Success Metrics

Clinical Success Rate
95.5%

Based on 21 completed trials

Completion Rate
95%(21/22)
Active Trials
7(15%)
Results Posted
19%(4 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
1
2%
Ph phase_4
4
9%
Ph not_applicable
26
57%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution31 total trials
Phase 2Efficacy & side effects
1(3.2%)
Phase 4Post-market surveillance
4(12.9%)
N/ANon-phased studies
26(83.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.3%

21 of 23 finished

Non-Completion Rate

8.7%

2 ended early

Currently Active

7

trials recruiting

Total Trials

46

all time

Status Distribution
Active(9)
Completed(21)
Terminated(2)
Other(14)

Detailed Status

Completed21
unknown14
Active, not recruiting4
Recruiting3
Enrolling by invitation2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
46
Active
7
Success Rate
95.5%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (3.2%)
Phase 44 (12.9%)
N/A26 (83.9%)

Trials by Status

unknown1430%
withdrawn12%
enrolling_by_invitation24%
terminated12%
active_not_recruiting49%
recruiting37%
completed2146%

Recent Activity

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT07446972

Impact of Bariatric Surgery on Female Sexual Function and Sex Hormones

Recruiting
NCT01501201Phase 4

Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients

Completed
NCT07600411Not Applicable

Binge Eating, Depression and Anxiety Outcomes After Sleeve Gastrectomy Versus Gastric Bypass: A Cohort Study

Recruiting
NCT05207917Not Applicable

How Does Bariatric Surgery Affect Social Experiences and Well-being - The BaSES-study

Enrolling By Invitation
NCT05365087

Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients

Active Not Recruiting
NCT00951093

Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass

Completed
NCT02128802Not Applicable

Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure

Completed
NCT04469712

Non-randomized Prospective Comparison Between SASI Bipartition and RYGB

Active Not Recruiting
NCT06752018

Inflammation's Impact on Heart Disease and Diabetes

Recruiting
NCT02386917Not Applicable

Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers

Active Not Recruiting
NCT01667783Phase 2

Improving Diabetes Through Lifestyle and Surgery

Completed
NCT02767505Not Applicable

Bypass Equipoise Sleeve Trial (BEST)

Active Not Recruiting
NCT02710786

Comorbidity After Gastric Bypass

Unknown
NCT03975478Not Applicable

Bariatric Surgery and LDL Cholesterol

Unknown
NCT02841527Not Applicable

Gastric Bypass, Gastric Band or Sleeve Gastrectomy to Treat Obesity

Completed
NCT05476159

Indocyanine Green Test in Bariatric Surgery

Completed
NCT01353118Not Applicable

The Effects of Glycemic Optimization Before Gastric Bypass Surgery

Completed
NCT00722995Not Applicable

Surgical Treatment for Morbid Obesity by Sleeve Gastrectomy Versus Gastric Bypass

Completed
NCT03339791Not Applicable

Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial

Completed
NCT02779322Not Applicable

Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
46